The cognitive dysfunction exhibited by these MAP
patients involves brain regions such as the prefrontal
cortex, which has dopaminergic systems vital
to the formation of attentional sets and switching
behavior16. Results support the assumption that
MAP patients, like methamphetamine users, have
altered dopamine function.